Sterling Investment Advisors (Pennsylvania)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sterling Investment Advisors (Pennsylvania)'s BMY Position: Q3 2022 in Review
Sterling Investment Advisors (Pennsylvania) sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 376 shares — an estimated $29K sold.
Sterling Investment Advisors (Pennsylvania) first reported a position in BMY in Q4 2016 and held it in 23 quarters. The position peaked at $1.92M in Q3 2017. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Sterling Investment Advisors (Pennsylvania) reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Sterling Investment Advisors (Pennsylvania) sold 376 Bristol-Myers Squibb shares in Q3 2022, an estimated $29K.
- Sterling Investment Advisors (Pennsylvania) first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 23 quarters.
- Sterling Investment Advisors (Pennsylvania)'s Bristol-Myers Squibb position peaked at $1.92M in Q3 2017.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.